Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FBGS is a Germany- and Belgium-based developer and manufacturer of fiber optic sensing components, interrogators, software, and turnkey sensing solutions built around Fiber Bragg Grating technology. The company commercializes proprietary Draw Tower Gratings (DTG), FemtoSecond Gratings (FSG), and All Grating Fiber (AGF) products for strain, temperature, pressure, shape, and force sensing applications. FBGS serves multiple end markets including medical technology, industrial process, infrastructure, transportation, composites, energy, telecom, and R&D. In healthcare, its sensing solutions are positioned to support minimally invasive and robotic procedures such as catheter-based interventions and force/shape sensing inside the body. The business appears to be a commercial-stage hardware and solutions company rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FBGS Technologies.